Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2015 1
2016 5
2017 1
2018 4
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.
Odin P, Ray Chaudhuri K, Slevin JT, Volkmann J, Dietrichs E, Martinez-Martin P, Krauss JK, Henriksen T, Katzenschlager R, Antonini A, Rascol O, Poewe W; National Steering Committees. Odin P, et al. Parkinsonism Relat Disord. 2015 Oct;21(10):1133-44. doi: 10.1016/j.parkreldis.2015.07.020. Epub 2015 Jul 23. Parkinsonism Relat Disord. 2015. PMID: 26233582 Free article. Review.
COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group. Santos-García D, et al. Among authors: Arbelo JM. BMC Neurol. 2016 Feb 25;16:26. doi: 10.1186/s12883-016-0548-9. BMC Neurol. 2016. PMID: 26911448 Free PMC article. Clinical Trial.
Clinical manifestations of intermediate allele carriers in Huntington disease.
Cubo E, Ramos-Arroyo MA, Martinez-Horta S, Martínez-Descalls A, Calvo S, Gil-Polo C; European HD Network. Cubo E, et al. Neurology. 2016 Aug 9;87(6):571-8. doi: 10.1212/WNL.0000000000002944. Epub 2016 Jul 8. Neurology. 2016. PMID: 27402890
LRRK2 Expression Is Deregulated in Fibroblasts and Neurons from Parkinson Patients with Mutations in PINK1.
Azkona G, López de Maturana R, Del Rio P, Sousa A, Vazquez N, Zubiarrain A, Jimenez-Blasco D, Bolaños JP, Morales B, Auburger G, Arbelo JM, Sánchez-Pernaute R. Azkona G, et al. Among authors: Arbelo JM. Mol Neurobiol. 2018 Jan;55(1):506-516. doi: 10.1007/s12035-016-0303-7. Epub 2016 Dec 14. Mol Neurobiol. 2018. PMID: 27975167 Free PMC article.
Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease.
Valldeoriola F, Grandas F, Santos-García D, Regidor I, Catalán MJ, Arbelo JM, Puente V, Mir P, Parra JC. Valldeoriola F, et al. Among authors: Arbelo JM. Neurodegener Dis Manag. 2016 Aug;6(4):289-98. doi: 10.2217/nmt-2016-0021. Epub 2016 Jul 21. Neurodegener Dis Manag. 2016. PMID: 27440190 Clinical Trial.
Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
Catalan MJ, Molina-Arjona JA, Mir P, Cubo E, Arbelo JM, Martinez-Martin P; EDIS Study Group. Catalan MJ, et al. Among authors: Arbelo JM. J Neurol. 2018 Jun;265(6):1279-1287. doi: 10.1007/s00415-018-8803-1. Epub 2018 Mar 20. J Neurol. 2018. PMID: 29557989 Clinical Trial.
Deep brain stimulation in parkinsonian patients with dopa intolerance.
García-Ruiz PJ, Feliz-Feliz C, Ayerbe Gracia J, Matías Arbelo J, Salvador C, Val Fernández JD, García-Caldentey J. García-Ruiz PJ, et al. Among authors: Matias Arbelo J. Neurocirugia (Astur). 2018 Jul-Aug;29(4):213-215. doi: 10.1016/j.neucir.2017.09.005. Epub 2017 Oct 28. Neurocirugia (Astur). 2018. PMID: 29089239 English, Spanish.
Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, Arbelo JM, Infante J, Kulisevsky J, Martínez-Martín P; COPPADIS Study Group. Santos-García D, et al. Among authors: Arbelo JM. BMC Neurol. 2016 Apr 6;16:44. doi: 10.1186/s12883-016-0567-6. BMC Neurol. 2016. PMID: 27053127 Free PMC article. No abstract available.
Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation.
Regidor I, Santos-García D, Catalán MIJ, Puente V, Valldeoriola F, Grandas F, Mir P, Parra JC, Arbelo JM. Regidor I, et al. Among authors: Arbelo JM. J Parkinsons Dis. 2019;9(1):173-182. doi: 10.3233/JPD-181324. J Parkinsons Dis. 2019. PMID: 30562907 Clinical Trial.
Psychometric Properties of the Apathy Scale in Advanced Parkinson's Disease.
Wetmore JB, Arbelo JM, Catalán MJ, Valldeoriola F, Rodriguez-Blazquez C, Martinez-Martin P. Wetmore JB, et al. Among authors: Arbelo JM. Parkinsons Dis. 2019 Mar 28;2019:1965394. doi: 10.1155/2019/1965394. eCollection 2019. Parkinsons Dis. 2019. PMID: 31031906 Free PMC article.
15 results
Jump to page
Feedback